medigraphic.com
ISSN 0185-6014 (Impreso)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2003, Número 2

<< Anterior Siguiente >>

Rev Mex Patol Clin Med Lab 2003; 50 (2)


Afecciones genitourinarias y micoplasmas

José Antonio Sánchez Hernández, José Antonio Rivera Tapia, Socorro Aradid Cortés Martínez, Nataly Tlecuitl Mendoza, Fabiola Méndez Valderrábano

Idioma: Español
Referencias bibliográficas: 18
Paginas: 71-76
Archivo PDF: 56.17 Kb.


RESUMEN

Las complicaciones derivadas de las infecciones por micoplasma incluyen desórdenes hematopoyéticos, cardiovasculares, del sistema nervioso central, musculoesqueléticos y gastrointestinales. El papel de los micoplasmas urogenitales, como es el caso de Mycoplasma hominis y Ureaplasma urealyticum, es polémico, pero pueden incluir infecciones del tracto genitourinario y durante el embarazo, como pulmonía y meningitis del neonato. Ureaplasma urealyticum, un comensal común del tracto urogenital humano, está ganando reconocimiento como un patógeno oportunista importante durante el embarazo. Mycoplasma hominis es susceptible a linezolid y evermicina, pero resistente a macrólidos y telitromicina. Por su parte, Ureaplasma urealyticum muestra susceptibilidad a evermicina y resistencia a linezolid.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Bebear C, Dupon M, Renaudin H, de Barbeyrac B. Potential improvements in therapeutic options for mycoplasmal respiratory infections. Clin Infect Dis 1993; 17 (suppl I): 202-207.

  2. Mernaugh GR, Dallo SF, Holt SC, Baseman JB. Properties of adhering and noradhering populations of Mycoplasma genitalium. Clin Infect Dis 1993; 17 (suppl I): 69-78.

  3. De Barbeyrac B, Bernet P et al. Detection of Mycoplasma pneumoniae and Mycoplasma genitalium in clinical samples by polimerase chain reaction. Clin Infect Dis 1993; 17 (suppl I): 83-89.

  4. Eschenbach DA. Ureaplasma urealyticum and premature birth. Clin Infect Dis 1993; 17 (suppl I): 100-106.

  5. Rodvold KA, Pisatelli SC. New oral macrolide and fluoroquinolone antibiotics: An overview of pharmacokinetics, interactions and safety. Clin Infect Dis 1993; 17 (suppl I):192-199.

  6. Taylor RD, Gilory CB, Hay PE. Ocurrence of Mycoplasma genitalium in different populations and its clinical significance. Clin Infect Dis 1993; 17 (suppl I): 66-68.

  7. Miller KE, Graves. Update on the prevention and treatment of sexually transmitted diseases. Am Fam Physician 2000; 61: 379-386.

  8. Bremnor J, Sadousky R. Evaluation of dysuria in adults. Am Fam Physician 2002; 65: 1589-1596.

  9. Tully JG. Current status of the Mollicute flora of humans. Clin Infect Dis 1993; 17 (suppl I): 2-9.

  10. Totten PA, Schwartz MA, Sjöström KE, Kenny GE, Handsfield HH, Weiss JB, Whittington WLH. Association of Mycoplasma genitalium with nongonococcal urethritis in heterosexual men. J Infect Dis 2001; 183: 269-276.

  11. Blanchard A, Hamrick W, Duffy L, Baldus K, Cassell GH. Use of the polymerase chain reaction for detection of Mycoplasma fermentans and Mycoplasma genitalium in the urogenital tract and amniotic fluid. Clin Infect Dis 1993; 17 (suppl I): 272-279.

  12. Blanchard A, Hentschel J, Duffy L, Baldus K, Cassell GH. Detection of Ureaplasma urealyticum by polymerase chain reaction in the urogenital tract of adults, in amniotic fluid, and in the respiratory tract of newborns. Clin Infect Dis 1993; 17 (suppl I): 148-153.

  13. Waites KB, Crouse DT, Cassell GH. Systemic neonatal infection due to Ureaplasma urealyticum. Clin Infect Dis 1993; 17 (suppl I): 131-135.

  14. Hyun YBO, Romero R, Kim M, Kim Tiu-Chong, Kim T et al. Clinical implications of detection of Ureaplasma urealyticum in the amniotic cavity with the polymerase chain reaction. Am J Obstet Gynecol 2000; 183: 1130-1137.

  15. Kenny GE, Cartwright FD. Effect of pH, inoculum size, and incubation time on the susceptibility of Ureaplasma urealyticum to erithromycin in vitro. Clin Infect Dis 1993; 17 (suppl I): 215-218.

  16. Waites KB, Crouse DT, Cassell GH. Therapeutic considerations for Ureaplasma urealyticum infections in neonates. Clin Infect Dis 1993; 17 (suppl I): 208-214.

  17. Mc. Conmack WM. Susceptibility of mycoplasma to antimicrobial agents: Clinical Implications. Clin Infect Dis 1993; 17 (suppl I): 200-201.

  18. Kenny GE, Cartwright FD. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromicin, evermicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines and quinolones. Antimicrob Agents Chemother 2001; 45: 2604-2608.




2020     |     www.medigraphic.com